Navigation Links
Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies
Date:1/3/2009

ents are then applied to the newly relaxed lip area with only need for a simple lip block as anesthesia. More than one laser treatment may be required depending on the depth of the wrinkles. Results will be evaluated after a 3 month final post-procedure time span to determine effectiveness of the combined treatment protocol.

Dr. Pilest is a Board Certified Dermatologist who has taken care of patients in the Orange County area for 30 years. His private practice, Total Dermatology, is located near the Spectrum in Irvine, California and is well known as one of Southern California's most comprehensive cosmetic laser centers.

Personalized cosmetic consultations with Dr. Pilest are complimentary. The office may be contacted by calling (949) 727 3800 or toll free at (877) DrPilest. Website: www.TotalDermatology.com

# # #

Read the full story at http://www.prweb.com/releases/dermatologist/irvine/prweb1803144.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
2. BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board
3. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
4. Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis
5. Board Certified Dermatologist and President-Elect of the Dermatologic Society of Greater New York, Dr. Lance H. Brown Takes His Comprehensive Practice to East Hampton, NY
6. Alimera Sciences Begins Pilot Study to Assess Safety and Efficacy of Iluvien(TM) in Patients With Bilateral Geographic Atrophy Due to AMD
7. SemBioSys begins phase I/II trial of insulin produced in plant seeds
8. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
9. TorreyPines Therapeutics Begins Dosing in a Phase I Multiple Dose Clinical Trial of NGX426, Oral Prodrug of Tezampanel
10. Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
11. The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Irvine Dermatologist Begins In-office Clinical Studies -- Nissan Pilest, MD Combines Multi-Use Botox in Laser Resurfacing Clinical Studies 
(Date:9/19/2014)... to move data would consume much less power ... as chips, transistor counts rise. , Of the ... emitters, modulators, and detectors emitters are the ... optical chips is molybdenum disulfide (MoS2), which has ... atom-thick layer. Other experimental on-chip light emitters have ...
(Date:9/19/2014)... SAN FRANCISCO , Sept. 19, 2014 /PRNewswire/ ... announced results from preclinical studies characterizing the analgesic ... oral, peripherally-acting kappa opioid receptor agonist molecules. The ... molecule polymer medicinal chemistry platform. The ... described in the medical literature. 1,2 Kappa ...
(Date:9/19/2014)... 2014 Cereal grain scientists, quality ... gather October 5–8, 2014, for the AACC International ... Center in Providence, Rhode Island. The comprehensive scientific ... food scientists, chemists, microbiologists, nutritionists, and those interested ... management. To date, 1,000 attendees have registered for ...
(Date:9/18/2014)... USA (PRWEB) September 18, 2014 Bipartisan ... of a bill designed to stimulate development and commercialization ... is being praised by leaders of SPIE, the ... the Revitalizing American Manufacturing and Innovation (RAMI) Act, now ... bill’s authors have said they are optimistic that it ...
Breaking Biology Technology:Toward optical chips 2Toward optical chips 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 3House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3
... ... EDMONTON, May 9 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS),a ... update on its pipeline products, HYC750 and development with,BioCyDex Inc., ... Bio. Inc. for HYC750, a technology based on hyaluronic acid that,has ...
... May 9 The Alexander von Humboldt,Foundation, one of ... has named Dr. Robert Knight as a winner of ... area of neurobiology.,It is the only prize that the ... Germany, the Humboldt Foundation reviews a,select group of international ...
... 9 ATS Medical, Inc. (Nasdaq:,ATSI), manufacturer and ... it will participate at the Rodman & Renshaw,5th ... Beach Plaza,Hotel in Monte Carlo on Tuesday, May ... Medical, will present at 9:20 a.m. local time., ...
Cached Biology Technology:BioMS Medical Provides Update On Pipeline Products 2BioMS Medical Provides Update On Pipeline Products 3NeuroFocus Chief Science Advisor Wins Humboldt Prize 2ATS Medical to Participate at the Rodman & Renshaw 5th Annual Global Healthcare Conference 2
(Date:9/18/2014)... ANTONIO, September 18, 2014 New research into the ... causes a severe hemorrhagic disease in humans similar to ... essential for CCHFV infection. This discovery has the potential ... the pathogen. , The research, reported in ... Pathogens and conducted by scientists at the Texas ...
(Date:9/18/2014)... prompts millions of Americans to undertake jaunts into the countryside ... little longer within a century, according to new research. , ... of the United States as summer temperatures linger later into ... Global Ecology and Biogeography . For instance, the paper birch ... of New Hampshire could change color one to three ...
(Date:9/18/2014)... across racial and ethnic groups describe losing eyesight ... day-to-day life, more so than other conditions including: ... of African-Americans, 49% of non-Hispanic whites, 43% of ... disease or ailment is the worst that could ... followed by AIDS/HIV. Hispanics and Asians ranked ...
Breaking Biology News(10 mins):Research milestone in CCHF virus could help identify new treatments 2Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3
... has won a $1.175 million grant that will support its ... Geurts, who has spent his career looking for clues to ... contents of gold, lead and other heavy atoms, said the ... constructing and commissioning a highly complex detector system to using ...
... that sheds new light on the causes of Parkinson,s disease, ... energy-producing machinery, the mitochondria. A shutdown in fuel can have ... of the body,s energy despite making up only 2 percent ... the mitochondria with FDA approved drugs early on may prevent ...
... billion last year in health research from all public ... That amount represents only 5.6% of the $2.47 trillion ... health dollarwhich varies no more than 0.2% from 2005 ... http://www.researchamerica.org/uploads/healthdollar09.pdf . The 2009 investment grew by ...
Cached Biology News:Grant advances quark-gluon plasma studies
 2Grant advances quark-gluon plasma studies
 3In Parkinson's disease, brain cells abandon mitochondria, researchers report 2In Parkinson's disease, brain cells abandon mitochondria, researchers report 3US invested $139 billion in health research in 2009 2
Roll of Mesh 5m x 25cm...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
... (PPase-2A) is a serine/threonine phosphatase isolated from ... as the heterodimer of 60kDa (A) and ... to dephosphorylate the a-subunit of phosphorylase kinase. ... broad substrate specificity and may play a ...
Immulon 2 HB 1x8 Strip assembled, C-bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
Biology Products: